Daniel Maus is an Analyst at Awad Capital where he supports the origination and execution of sell-side and buy-side M&A transactions, as well as capital-raising efforts.

Daniel has a diverse background in Investment Banking, with experience across Germany, Switzerland, and the UAE. He previously completed his summer internship at Awad Capital and gained further experience in the GSA M&A Coverage Team at Saxenhammer. He also worked with the Healthcare M&A Team at Patient21, a BlackRock-backed health tech startup. Additionally, Daniel has experience in the CEO Strategy Team at Fresenius and the Audit Team at Deloitte.

Daniel holds a bachelor’s degree in economics from the University of Mannheim and is passionate about fitness, traveling, and playing paddle.